Zobrazeno 1 - 10
of 325
pro vyhledávání: '"McMullin, M"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
McMullin, M. F.
Publikováno v:
BMJ: British Medical Journal, 2000 May . 320(7245), 1317-1317.
Externí odkaz:
https://www.jstor.org/stable/25224508
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Harrison, C, Mendez-Ferrer, S, Houlton, A, Sirovica, M, Drummond, M, McMullin, M, Mead, A, Milojkovic, D, Ewing, J, Cargo, C, Butt, N, Wadelin, F, Chen, F, Coppell, J, Francis, S, Narayanan, S, Knapper, S, Godfrey, A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::04ac997387256e1736a296e543e9e1aa
https://ora.ox.ac.uk/objects/uuid:9c482006-9511-407a-9b1a-201106f4d7be
https://ora.ox.ac.uk/objects/uuid:9c482006-9511-407a-9b1a-201106f4d7be
Publikováno v:
McMullan, R R, McConville, C & McMullin, M F 2019, ' Response to Therapy, Treatment Intolerance and Tyrosine Kinase Inhibitor Cessation Eligibility in a Real-World Cohort of Chronic Myeloid Leukaemia Patients ', The Ulster Medical Journal, vol. 88, no. 2, pp. 105-110 .
Tyrosine kinase inhibitor (TKI) therapy has revolutionised chronic myeloid leukaemia (CML) management, it is however associated with significant side effects and economic burden. Recent studies have demonstrated that treatment free remission is possi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2607::9ed610c60dc054201392dee5c654c83d
https://pure.qub.ac.uk/en/publications/6fc802f4-0973-4cbd-bf37-3094ab5ec95e
https://pure.qub.ac.uk/en/publications/6fc802f4-0973-4cbd-bf37-3094ab5ec95e
Autor:
McMullin, M. F.1
Publikováno v:
International Journal of Laboratory Hematology. May2016 Supplement, Vol. 38, p59-65. 7p.
Publikováno v:
Daly, A B, Cuthbert, R, Finnegan, D, Arnold, C, Craddock, C & McMullin, M F 2019, ' A Comparison of Inpatient and Outpatient-Based Chemotherapy Regimens for the Treatment of Acute Myeloid Leukaemia In The Elderly ', The Ulster Medical Journal, vol. 88, no. 1, pp. 25-29 . < https://www.ums.ac.uk/umj088/088(1)025.pdf >
Introduction: Acute myeloid leukaemia (AML) is an aggressive haematological malignancy which is more common in the elderly and has a poor 5-year survival. There are no established beneficial interventions to treat AML in elderly patients. It is uncle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2607::f9bdeb04d0275ab1a5b4cf05fa0ab8b0
https://pure.qub.ac.uk/en/publications/9c373c9a-cb63-40e3-9eea-0988fa44590a
https://pure.qub.ac.uk/en/publications/9c373c9a-cb63-40e3-9eea-0988fa44590a
Autor:
McMullin, M. F., Harrison, C. N., Ali, S., Cargo, C., Chen, F., Ewing, J, Garg, M., Godfrey, A., Knapper, Steven, McLorcan, D., Nangalia, J., Sekhar, M., Wadelin, F., Mead, A. J.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::5f75cb2215101178b239c64f37452340
Autor:
McMullin, M, Mead, A, Ali, S, Cargo, C, Chen, F, Ewing, J, Garg, M, Godfrey, A, Knapper, S, McLornan, D, Nangalia, J, Sekhar, M, Wadelin, F, Harrison, C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2851a2f61d2fe7672db488dfc9263009
https://doi.org/10.1111/bjh.15647
https://doi.org/10.1111/bjh.15647